BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
1 – 10 of 3089
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction
(
- Contribution to journal › Article
-
Mark
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI) : a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
(
- Contribution to journal › Article
- 2024
-
Mark
Closed and open structures of the eukaryotic magnesium channel Mrs2 reveal the auto-ligand-gating regulation mechanism
2024) In Nature Structural and Molecular Biology(
- Contribution to journal › Article
- 2019
-
Mark
Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors : an international survey
(
- Contribution to journal › Article
-
Mark
Quality of Life After Open Radical Prostatectomy Compared with Robot-assisted Radical Prostatectomy
(
- Contribution to journal › Article
-
Mark
Comparison between software volumetric breast density estimates in breast tomosynthesis and digital mammography images in a large public screening cohort
(
- Contribution to journal › Article
-
Mark
Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients : predictors of testing uptake
(
- Contribution to journal › Article
-
Mark
PO-0978 Accurate positioning with decreased treatment time using surface guided tomotherapy : ESTRO 38, 26-30 April 2019, Milan, Italy
(
- Contribution to journal › Published meeting abstract
-
Mark
A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden
(
- Contribution to journal › Article
-
Mark
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
(
- Contribution to journal › Article